Cartesian Therapeutics (RNAC) Enterprise Value (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Enterprise Value of -$118.6 million for Q1 2026, up 34.25% year-over-year from -$88.4 million in Q1 2025, and up 5.19% quarter-over-quarter from -$125.1 million in Q4 2025.
Cartesian Therapeutics (RNAC) Enterprise Value (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Enterprise Value data on file, last reported at -$118.6 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$118.6 million, up 34.25% year-over-year; the trailing twelve-month figure through Mar 2026 was -$118.6 million (up 34.25% YoY), and the FY2025 annual result was -$125.1 million, up 41.14% from the prior year.
- Enterprise Value rose to -$118.6 million in Q1 2026 per RNAC's latest filing, from -$125.1 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$76.9 million in Q4 2023 and troughed at -$219.2 million in Q3 2024.
- A 5-year average of -$134.4 million and a median of -$125.9 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value surged 45.64% in 2023, then plunged 176.44% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$134.6 million in 2022, then soared by 42.86% to -$76.9 million in 2023, then tumbled by 176.44% to -$212.6 million in 2024, then surged by 41.14% to -$125.1 million in 2025, then grew by 5.19% to -$118.6 million in 2026.
- Business Quant data shows RNAC's Enterprise Value at -$118.6 million in Q1 2026, -$125.1 million in Q4 2025, and -$143.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | -118.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -118.64 Mn |
| Dec 31, 2025 | -125.14 Mn |
| Sep 30, 2025 | -143.38 Mn |
| Jun 30, 2025 | -160.32 Mn |
| Mar 31, 2025 | -180.43 Mn |
| Dec 31, 2024 | -212.61 Mn |
| Sep 30, 2024 | -219.20 Mn |
| Jun 30, 2024 | -87.23 Mn |
| Mar 31, 2024 | -103.42 Mn |
| Dec 31, 2023 | -76.91 Mn |
| Sep 30, 2023 | -79.60 Mn |
| Jun 30, 2023 | -112.03 Mn |
| Mar 31, 2023 | -125.93 Mn |
| Dec 31, 2022 | -134.60 Mn |
| Sep 30, 2022 | -146.44 Mn |
| Jun 30, 2022 | -142.06 Mn |
| Mar 31, 2022 | -117.43 Mn |
| Dec 31, 2021 | -128.06 Mn |
| Sep 30, 2021 | -138.66 Mn |
| Jun 30, 2021 | -150.14 Mn |